Mario M Leitao

Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted?

D. Levine, R. Barakat, D. Chi, 2013, Gynecologic oncology.

Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer

N. Abu-Rustum, D. Zamarin, Jennifer J Mueller, 2024, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation

A. Iasonos, B. Manning-Geist, N. Abu-Rustum, 2024, International Journal of Gynecological Cancer.

Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study.

A. Iasonos, G. Gardner, O. Zivanovic, 2023, Gynecologic oncology.